Invex Therapeutics Ltd (ASX:IXC)
0.130
-0.010 (-7.14%)
Apr 29, 2026, 12:28 PM AEST
73.33% (1Y)
| Market Cap | 9.77M |
| Revenue (ttm) | 229.08K |
| Net Income (ttm) | -835.92K |
| Shares Out | 75.15M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 80,687 |
| Average Volume | 35,976 |
| Open | 0.140 |
| Previous Close | 0.140 |
| Day's Range | 0.130 - 0.140 |
| 52-Week Range | 0.074 - 0.180 |
| Beta | 0.37 |
| RSI | 64.78 |
| Earnings Date | May 13, 2026 |